23

Oct

2018

18:00

BST

Live Stream

Expanding Vascular Access Options in TAVI

Average (ratings)
No ratings
Your rating

Overview

Transcatheter aortic valve implantation (TAVI) has emerged to be a viable treatment option for patients suffering from Severe Aortic Stenosis.

The transfemoral approach is the most common access route for TAVI and associated with most favourable clinical outcomes.

However, with a population with increasingly complex vasculature, the incidence of vascular complications in TAVI remains high. Careful planning, meticulous technique and the emergence of sophisticated devices are essential to obtain the best possible outcome.

The aim of the live case will be to feature a live procedure using the self-expanding ACURATE neo™ TF system along with the iSLEEVE Expandable Introducer Set and share the experience of a high-volume centre when it comes to vascular access and minimizing complications.

Faculty:


Dr Won-Keun Kim

Dr Won-Keun Kim

This live stream is sponsored by Boston Scientific Corporation

Learning Objectives

  • Transfemoral TAVI with Acurate neo™ and iSLEEVE Introducer Set: Device description, key benefits, and an overview of the clinical data.
  • How to minimize vascular complication with a careful planning and unique technique: Experience from a high volume center.
  • How to optimize each step of a TAVI procedure to achieve a safe and efficient procedure:
  • Preoperative imaging
  • US guided puncture
  • Suture device
  • Sedative protocol
  • LV pacing wire
  • Low calibre access sheath
  • Low pacemaker & complication device
  • Vascular closure

Target Audience

  • TAVI implanters (non/early-experienced implanters)
  • Cardiologists
  • Geographies not familiar with the ACURATE neo device

Faculty Biographies


Dr Won-Keun Kim

Dr Won-Keun Kim

Dr Won-Keun Kim is an Interventional Cardiologist and Deputy Director of Cardiology & Angiology at University of Giessen & Marburg, Giessen, DE. 

View full profile

Key References

1. Won-Keun Kim, MD et al. 1-Year Outcomes of the European Post-Market Registry Using the ACURATE neo Transcatheter Heart Valve Under Real-World Conditions in 1,000 Patients. JACC: Cardiovascular Interventions. 2018; 11: 1368–74.

2. Möllmann H, Hengstenberg C, et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI-TF registry. EuroIntervention. 2018;13: 1764-1770